China Pharma Holdings Inc.

0.6375-0.0049-0.76%Vol 96.68K1Y Perf 76.26%
Sep 15th, 2021 15:59 DELAYED
BID0.6350 ASK0.6499
Open0.6316 Previous Close0.6424
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     28.12
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     19.55
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
22.76 
Earnings Rating
Buy
Market Cap27.78M 
Earnings Date
13th Aug 2021
Alpha0.04 Standard Deviation0.25
Beta0.10 

Today's Price Range

0.62000.6499

52W Range

0.34501.63

5 Year PE Ratio Range

-0.9000-1.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.84%
1 Month
-13.85%
3 Months
-12.52%
6 Months
-37.50%
1 Year
76.26%
3 Years
189.77%
5 Years
165.63%
10 Years
-59.39%

TickerPriceChg.Chg.%
CPHI0.6375-0.0049-0.76
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
0.20
0.40
0.06
1.23
-11.20
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
9.40
-34.60
-7.20
-104.20
-38.24
RevenueValueIndustryS&P 500US Markets
10.11M
0.23
-7.04
-8.15
Earnings HistoryEstimateReportedSurprise %
Q02 2021--0.02-
Q01 2021--0.02-
Q03 2020--0.02-
Q02 2020-0.00-
Q01 2020--0.02-
Q04 2019--0.43-
Q03 2019--0.02-
Q02 2019--0.02-
Earnings Per EndEstimateRevision %Trend
3/2012 QR---
6/2012 QR---
12/2012 FY---
12/2013 FY---
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume96.68K
Shares Outstanding43.58M
Shares Float22.22M
Trades Count349
Dollar Volume679.48K
Avg. Volume1.79M
Avg. Weekly Volume202.48K
Avg. Monthly Volume359.11K
Avg. Quarterly Volume906.23K

China Pharma Holdings Inc. (AMEX: CPHI) stock closed at 0.6375 per share at the end of the most recent trading day (a -0.76% change compared to the prior day closing price) with a volume of 96.92K shares and market capitalization of 27.78M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 242 people. China Pharma Holdings Inc. CEO is Zhilin Li.

The one-year performance of China Pharma Holdings Inc. stock is 76.26%, while year-to-date (YTD) performance is 41.67%. CPHI stock has a five-year performance of 165.63%. Its 52-week range is between 0.345 and 1.63, which gives CPHI stock a 52-week price range ratio of 22.76%

China Pharma Holdings Inc. currently has a PE ratio of -7.40, a price-to-book (PB) ratio of 4.48, a price-to-sale (PS) ratio of 2.89, a price to cashflow ratio of 58.70, a PEG ratio of 2.32, a ROA of -17.17%, a ROC of -23.95% and a ROE of -49.53%. The company’s profit margin is -38.24%, its EBITDA margin is -7.20%, and its revenue ttm is $10.11 Million , which makes it $0.23 revenue per share.

Of the last four earnings reports from China Pharma Holdings Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Pharma Holdings Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for China Pharma Holdings Inc. is (0), with a target price of $, which is 0.00% compared to the current price. The earnings rating for China Pharma Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

China Pharma Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

China Pharma Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 31.30, ATR14 : 0.04, CCI20 : -168.39, Chaikin Money Flow : -0.05, MACD : -0.03, Money Flow Index : 25.12, ROC : -9.88, RSI : 32.31, STOCH (14,3) : 14.83, STOCH RSI : 0.00, UO : 45.35, Williams %R : -85.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of China Pharma Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablet, clarithromycin granule, roxithromycin dispersible tablet, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

CEO: Zhilin Li

Telephone: +86 89866811730

Address: Second Floor, No. 17, Jinpan Road, Haikou 570216, , CN

Number of employees: 242

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

News

Stocktwits